Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment

The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections

(2014)   OPHTHALMOLOGY

ANTI-VEGF TREATMENT IN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION

(2014) Farshad Abedi et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Comparison of Outcomes from a Phase 3 Study of Age-Related Macular Degeneration with a Matched, Observational Cohort

(2013) Mark C. Gillies et al.   OPHTHALMOLOGY

Time Trends in the Incidence and Causes of Blindness in Israel

(2012) Alon Skaat et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Changing Trends of Blindness: The Initial Harvest From Translational Public Health and Clinical Research in Ophthalmology

(2012) Ning Cheung et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010

(2012) Sara Brandi Bloch et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Impact of Availability of Anti–Vascular Endothelial Growth Factor Therapy on Visual Impairment and Blindness Due to Neovascular Age-Related Macular Degeneration

(2012) John P. Campbell et al.   ARCHIVES OF OPHTHALMOLOGY

Age-related macular degeneration

(2012) Laurence S Lim et al.   LANCET

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

(2012) Daniel F. Martin et al.   OPHTHALMOLOGY

Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization

(2011) Neil M. Bressler et al.   ARCHIVES OF OPHTHALMOLOGY

Neovascular AMD: an overlooked risk factor for injurious falls

(2009) S. M. Szabo et al.   OSTEOPOROSIS INTERNATIONAL

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY